Cargando…
Decisive Conditions for Strategic Vaccination against SARS-CoV-2
While vaccines against SARS-CoV-2 are being administered, in most countries it may still take months until their supply can meet demand. The majority of available vaccines elicits strong immune responses when administered as prime-boost regimens. Since the immunological response to the first (“prime...
Autores principales: | Böttcher, Lucas, Nagler, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987045/ https://www.ncbi.nlm.nih.gov/pubmed/33758886 http://dx.doi.org/10.1101/2021.03.05.21252962 |
Ejemplares similares
-
Timing vaccination against SARS-CoV-2
por: Barnoud, Coline, et al.
Publicado: (2021) -
Strategic Role and Challenges of Community Pharmacists in SARS-CoV-2 Outbreak
por: Talukdar, Debjyoti, et al.
Publicado: (2021) -
Anti-SARS-CoV-2 hyperimmune immunoglobulins, an urgent strategic choice
Publicado: (2020) -
Translating SARS-CoV-2 wastewater-based epidemiology for prioritizing mass vaccination: a strategic overview
por: Dharmadhikari, Tanmay, et al.
Publicado: (2021) -
SARS-CoV-2 strategically mimics proteolytic activation of human ENaC
por: Anand, Praveen, et al.
Publicado: (2020)